SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Ann Richards

PatientAnn Richards
Date of birth1962-09-01
IdentifiersMRN HR-ML019-SYN; SSN (made up) 000-19-3381
Document date2026-02-10
AuthorRosalind Teague, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for new patient visit for bone health after a fall with a hand fracture. [S]

Objective

Lumbar spine (L1-L4) T-score: -2.3 (low); Femoral neck T-score: -2 (low); Total hip T-score: -1.7 (low); FRAX 10-year major osteoporotic fracture risk: 22%; FRAX 10-year hip fracture risk: 3.6%; Calcium: 9.4 mg/dL; Albumin: 4.2 g/dL; Creatinine: 0.8 mg/dL; eGFR: 81 mL/min/1.73 m²; Phosphate: 3.5 mg/dL; Magnesium: 2 mg/dL; Alkaline phosphatase: 84 U/L; PTH: 54 pg/mL; TSH: 1.9 mIU/L; Hemoglobin: 13.3 g/dL; ALT: 21 U/L; 25-hydroxyvitamin D: 24 ng/mL (low); Serum CTX (fasting morning sample): 560 pg/mL; PHQ-9: 2; AUDIT-C: 0. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-02-10Body height164cmS
2026-02-10Body weight66kgS
2026-02-10Body mass index (BMI) [Ratio]24.5kg/m2S
2026-02-10Systolic blood pressure124mm[Hg]S
2026-02-10Diastolic blood pressure76mm[Hg]S
2026-02-10Heart rate72/minS
2026-02-10Respiratory rate14/minS
2026-02-10Body temperature36.6CelS
2026-02-10Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-10DXA Lumbar spine [T-score] Bone density-2.3{T-score}-1.0 or higher is normal; between -1.0 and -2.5 is low bone mass (osteopenia); -2.5 or lower is osteoporosisLowS
2026-02-10DXA Femur [T-score] Bone density-2{T-score}-1.0 or higher is normal; between -1.0 and -2.5 is low bone mass (osteopenia); -2.5 or lower is osteoporosisLowS
2026-02-10DXA Hip [T-score] Bone density-1.7{T-score}-1.0 or higher is normal; between -1.0 and -2.5 is low bone mass (osteopenia); -2.5 or lower is osteoporosisLowS
2026-02-10Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment22%S
2026-02-10Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment3.6%S
2026-02-10Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.3 mg/dLNormalS
2026-02-10Albumin [Mass/volume] in Serum or Plasma4.2g/dL3.5-5 g/dLNormalS
2026-02-10Creatinine [Mass/volume] in Serum or Plasma0.8mg/dL0.5-1 mg/dLNormalS
2026-02-10Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M81mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-02-10Phosphate [Mass/volume] in Serum or Plasma3.5mg/dL2.5-4.5 mg/dLNormalS
2026-02-10Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.7-2.4 mg/dLNormalS
2026-02-10Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma84U/L40-120 U/LNormalS
2026-02-10Parathyrin.intact [Mass/volume] in Serum or Plasma54pg/mL15-65 pg/mLNormalS
2026-02-10Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.4-4 mIU/LNormalS
2026-02-10Hemoglobin [Mass/volume] in Blood13.3g/dL12-15.5 g/dLNormalS
2026-02-10Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma21U/L7-35 U/LNormalS
2026-02-1025-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma24ng/mLTarget 30 ng/mL or higher before and during osteoporosis treatmentLowS
2026-02-10Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma560pg/mLPostmenopausal reference interval 104 to 1008 pg/mL; a fall of more than about 30 percent on antiresorptive therapy indicates responseNormalS
2026-02-10Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S
2026-02-10Total score [AUDIT-C]0{score}S

Medications

MedicationFrequencyRouteDatesStatusEvidence
Cholecalciferol (vitamin D3) 50 mcg (2000 units) oral tablet, one tablet dailyOne tablet by mouth dailyOral route2026-02-10activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Low bone mass (osteopenia) of the lumbar spine and hip on DXA, lowest T-score -2.3 at the lumbar spine (femoral neck -2.0, total hip -1.7), with a 10-year FRAX risk above the treatment thresholds (major osteoporotic fracture 22 percent, hip 3.6 percent); not osteoporosis by T-score, but meets the AACE 2020 clinical criteria for osteoporosis (low bone mass with a FRAX risk above threshold)activeconfirmed M85.89S — Synthetic modern DXA and FRAX classification linked to her publicly described osteopenia (early osteoporosis) after a fall with a hand fracture.
Alcohol use disorder in sustained remission for more than fifteen years, since treatment; no alcohol sinceactiveconfirmed F10.21S — Synthetic modern coding of her publicly described heavy drinking and long recovery; listed because remission protects bone and lowers fall risk, and it is reviewed at each visit.
History of falls: a fall from standing height with a hand fracture last year (and, in one account, a second fall with an ankle fracture); no falls sinceactiveconfirmed Z91.81S — Synthetic modern entry linked to her publicly described falls and fractures.

Assessment

Plan of Treatment